Nano-structured chitosan self-aggregates as a drug delivery carrier

Min Su Bae, Ick Chan Kwon, Seo Young Jeong, Kuen Yong Lee

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Colloidal delivery systems including polymeric self-aggregates have been widely investigated to date, as these formulations may reduce unwanted side effects and may improve the therapeutic effects. Various characteristics of self-aggregates prepared from deoxycholic acid-modified chitosan were investigated by fluorescence spectroscopic and dynamic light scattering methods, and found to be controlled by the degree of substitution of hydrophobic groups, and pH and ionic strength of the medium. Chitosan self-aggregates can form complexes with plasmid DNA, and can be used to transfect COS-1 cells in vitro. Adriamycin can be also entrapped into chitosan self-aggregates and released in a sustained manner in vitro. These self-aggregates may find potential applications as a delivery vehicle of genes and anti-cancer drugs.

Original languageEnglish
Title of host publication2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings
EditorsM. Laudon, B. Romanowicz
Pages164-167
Number of pages4
Publication statusPublished - 2005 Dec 1
Externally publishedYes
Event2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 - Anaheim, CA, United States
Duration: 2005 May 82005 May 12

Other

Other2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005
CountryUnited States
CityAnaheim, CA
Period05/5/805/5/12

Fingerprint

Drug delivery
Chitosan
Dynamic light scattering
Ionic strength
DNA
Substitution reactions
Genes
Fluorescence
Acids

Keywords

  • Adriamycin
  • Chitosan
  • DNA
  • Self-aggregates

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Bae, M. S., Kwon, I. C., Jeong, S. Y., & Lee, K. Y. (2005). Nano-structured chitosan self-aggregates as a drug delivery carrier. In M. Laudon, & B. Romanowicz (Eds.), 2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings (pp. 164-167)

Nano-structured chitosan self-aggregates as a drug delivery carrier. / Bae, Min Su; Kwon, Ick Chan; Jeong, Seo Young; Lee, Kuen Yong.

2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings. ed. / M. Laudon; B. Romanowicz. 2005. p. 164-167.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Bae, MS, Kwon, IC, Jeong, SY & Lee, KY 2005, Nano-structured chitosan self-aggregates as a drug delivery carrier. in M Laudon & B Romanowicz (eds), 2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings. pp. 164-167, 2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005, Anaheim, CA, United States, 05/5/8.
Bae MS, Kwon IC, Jeong SY, Lee KY. Nano-structured chitosan self-aggregates as a drug delivery carrier. In Laudon M, Romanowicz B, editors, 2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings. 2005. p. 164-167
Bae, Min Su ; Kwon, Ick Chan ; Jeong, Seo Young ; Lee, Kuen Yong. / Nano-structured chitosan self-aggregates as a drug delivery carrier. 2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings. editor / M. Laudon ; B. Romanowicz. 2005. pp. 164-167
@inproceedings{2f73887125314090a50fc3b02c7355f4,
title = "Nano-structured chitosan self-aggregates as a drug delivery carrier",
abstract = "Colloidal delivery systems including polymeric self-aggregates have been widely investigated to date, as these formulations may reduce unwanted side effects and may improve the therapeutic effects. Various characteristics of self-aggregates prepared from deoxycholic acid-modified chitosan were investigated by fluorescence spectroscopic and dynamic light scattering methods, and found to be controlled by the degree of substitution of hydrophobic groups, and pH and ionic strength of the medium. Chitosan self-aggregates can form complexes with plasmid DNA, and can be used to transfect COS-1 cells in vitro. Adriamycin can be also entrapped into chitosan self-aggregates and released in a sustained manner in vitro. These self-aggregates may find potential applications as a delivery vehicle of genes and anti-cancer drugs.",
keywords = "Adriamycin, Chitosan, DNA, Self-aggregates",
author = "Bae, {Min Su} and Kwon, {Ick Chan} and Jeong, {Seo Young} and Lee, {Kuen Yong}",
year = "2005",
month = "12",
day = "1",
language = "English",
isbn = "0976798506",
pages = "164--167",
editor = "M. Laudon and B. Romanowicz",
booktitle = "2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings",

}

TY - GEN

T1 - Nano-structured chitosan self-aggregates as a drug delivery carrier

AU - Bae, Min Su

AU - Kwon, Ick Chan

AU - Jeong, Seo Young

AU - Lee, Kuen Yong

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Colloidal delivery systems including polymeric self-aggregates have been widely investigated to date, as these formulations may reduce unwanted side effects and may improve the therapeutic effects. Various characteristics of self-aggregates prepared from deoxycholic acid-modified chitosan were investigated by fluorescence spectroscopic and dynamic light scattering methods, and found to be controlled by the degree of substitution of hydrophobic groups, and pH and ionic strength of the medium. Chitosan self-aggregates can form complexes with plasmid DNA, and can be used to transfect COS-1 cells in vitro. Adriamycin can be also entrapped into chitosan self-aggregates and released in a sustained manner in vitro. These self-aggregates may find potential applications as a delivery vehicle of genes and anti-cancer drugs.

AB - Colloidal delivery systems including polymeric self-aggregates have been widely investigated to date, as these formulations may reduce unwanted side effects and may improve the therapeutic effects. Various characteristics of self-aggregates prepared from deoxycholic acid-modified chitosan were investigated by fluorescence spectroscopic and dynamic light scattering methods, and found to be controlled by the degree of substitution of hydrophobic groups, and pH and ionic strength of the medium. Chitosan self-aggregates can form complexes with plasmid DNA, and can be used to transfect COS-1 cells in vitro. Adriamycin can be also entrapped into chitosan self-aggregates and released in a sustained manner in vitro. These self-aggregates may find potential applications as a delivery vehicle of genes and anti-cancer drugs.

KW - Adriamycin

KW - Chitosan

KW - DNA

KW - Self-aggregates

UR - http://www.scopus.com/inward/record.url?scp=32044435590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32044435590&partnerID=8YFLogxK

M3 - Conference contribution

SN - 0976798506

SP - 164

EP - 167

BT - 2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings

A2 - Laudon, M.

A2 - Romanowicz, B.

ER -